Cocrystal Pharma, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Cocrystal Pharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Cocrystal Pharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$4.94M, a 18.6% decline year-over-year.
  • Cocrystal Pharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$18.7M, a 3.78% decline year-over-year.
  • Cocrystal Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$18M, a 53.7% increase from 2022.
  • Cocrystal Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$38.8M, a 174% decline from 2021.
  • Cocrystal Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$14.2M, a 47% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$18.7M -$4.94M -$774K -18.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$17.9M -$5.34M -$1.18M -28.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-13
Q1 2024 -$16.8M -$3.96M +$1.23M +23.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-13
Q4 2023 -$18M -$4.46M +$37K +0.82% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$18M -$4.17M +$1.54M +26.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$19.6M -$4.17M +$20.3M +82.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-13
Q1 2023 -$39.8M -$5.19M -$981K -23.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-13
Q4 2022 -$38.8M -$4.5M -$816K -22.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$38M -$5.7M -$1.76M -44.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$36.3M -$24.4M -$20.6M -539% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 -$15.7M -$4.21M -$1.47M -53.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
Q4 2021 -$14.2M -$3.69M -$2.19M -147% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 -$12M -$3.94M -$1.27M -47.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$10.7M -$3.82M -$326K -9.33% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$10.4M -$2.74M -$748K -37.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$9.65M -$1.49M +$46.4M +96.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-23
Q3 2020 -$56M -$2.67M -$890K -50% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$55.1M -$3.5M -$1.98M -131% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$53.1M -$1.99M -$4.96M -167% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
Q4 2019 -$48.2M -$47.8M -$3.56M -8.04% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-17
Q3 2019 -$44.6M -$1.78M +$88K +4.71% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$44.7M -$1.52M -$172K -12.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-13
Q1 2019 -$44.5M $2.97M +$4.52M Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-13
Q4 2018 -$49M -$44.3M -$49.2M -1004% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 $135K -$1.87M +$92K +4.69% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $43K -$1.34M +$917K +40.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-12
Q1 2018 -$874K -$1.55M +$997K +39.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-12
Q4 2017 -$1.87M $4.9M +$70.7M Oct 1, 2017 Dec 31, 2017 10-K 2018-03-21
Q3 2017 -$72.5M -$1.96M -$79K -4.2% Jul 1, 2017 Sep 30, 2017 10-K 2018-03-21
Q2 2017 -$72.4M -$2.26M +$967K +30% Apr 1, 2017 Jun 30, 2017 10-Q 2018-11-09
Q1 2017 -$73.4M -$2.55M +$1.46M +36.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$74.9M -$65.8M -$35.3M -116% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-21
Q3 2016 -$39.6M -$1.88M -$1.37M -270% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-21
Q2 2016 -$38.2M -$3.23M -$604K -23% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-21
Q1 2016 -$37.6M -$4.01M +$12.5M +75.7% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-21
Q4 2015 -$50.1M -$30.4M -$28.5M -1496% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$21.6M -$508K +$2.04M +80.1% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-31
Q2 2015 -$23.6M -$2.62M -$7.35M -155% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-31
Q1 2015 -$16.3M -$16.5M -$16.2M -4347% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-31
Q4 2014 -$99K -$1.91M -$1.11M -140% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-31
Q3 2014 $1.02M -$2.55M -$1.54M -154% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 $2.56M $4.73M +$5.76M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$3.2M -$372K +$686K +64.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 -$3.89M -$794K +$2.71M +77.3% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 -$6.6M -$1.01M -$906K -918% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$5.69M -$1.03M -$316K -44.2% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$5.38M -$1.06M +$2.59M +71% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$7.96M -$3.51M -$1.13M -47.5% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 -$6.84M -$98.7K +$2.4M +96.1% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-18
Q2 2012 -$9.24M -$714K -$146K -25.7% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-15
Q1 2012 -$9.09M -$3.65M -$3.63M -27324% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 -$5.46M -$2.38M Oct 1, 2011 Dec 31, 2011 10-K 2013-04-01
Q3 2011 -$2.5M -$2.76M -1073% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$568K -$627K -1064% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-28
Q1 2011 -$13.3K Jan 1, 2011 Mar 31, 2011 10-Q/A 2012-10-02
Q3 2010 $257K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-21
Q2 2010 $59K Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.